Intercept Pharmaceuticals reported $222.86M in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 37.35B 193M
AstraZeneca AZN:LN USD 23.68B 3.47B
Biogen BIIB:US USD 6.28B 1.8M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Esperion Therapeutics ESPR:US USD 259.49M 407K
Galectin Therapeutics GALT:US USD 29.73M 230K
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Moderna Inc MRNA:US USD 922M 281M
Novartis NOVN:VX USD 21.78B 547M
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 30.48M 681K